Clifford Capital Partners LLC increased its stake in shares of Stericycle, Inc. (NASDAQ:SRCL – Free Report) by 17.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 320,589 shares of the business services provider’s stock after purchasing an additional 47,729 shares during the quarter. Stericycle makes up 4.1% of Clifford Capital Partners LLC’s holdings, making the stock its 3rd largest position. Clifford Capital Partners LLC owned 0.35% of Stericycle worth $18,636,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds also recently added to or reduced their stakes in SRCL. Clearstead Trust LLC acquired a new position in Stericycle during the 1st quarter valued at about $25,000. International Assets Investment Management LLC acquired a new position in shares of Stericycle during the second quarter valued at about $45,000. GAMMA Investing LLC raised its position in shares of Stericycle by 170.9% in the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after purchasing an additional 516 shares during the last quarter. Headlands Technologies LLC acquired a new stake in Stericycle in the 1st quarter worth approximately $44,000. Finally, TFO Wealth Partners LLC boosted its stake in Stericycle by 22,325.0% in the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after purchasing an additional 893 shares in the last quarter. Hedge funds and other institutional investors own 98.82% of the company’s stock.
Stericycle Price Performance
Shares of SRCL opened at $60.94 on Wednesday. The business’s 50-day moving average is $59.72 and its two-hundred day moving average is $55.29. The company has a market capitalization of $5.66 billion, a P/E ratio of -277.00, a P/E/G ratio of 3.33 and a beta of 1.11. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $61.77. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on SRCL. Truist Financial upped their price target on shares of Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, June 4th. Royal Bank of Canada restated a “sector perform” rating and issued a $62.00 target price (down previously from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. StockNews.com began coverage on Stericycle in a research note on Wednesday, September 25th. They set a “hold” rating on the stock. Finally, Keefe, Bruyette & Woods raised their price objective on Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $74.00.
View Our Latest Stock Analysis on Stericycle
Stericycle Profile
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
See Also
- Five stocks we like better than Stericycle
- Comparing and Trading High PE Ratio Stocks
- Ready for Growth? Barrick Gold Stock Could Be the Answer
- How to Capture the Benefits of Dividend Increases
- Trade Like a Member of Congress With These 2 ETFs
- How to Calculate Options Profits
- October’s Top 3 Stocks Revealed by MarketBeat’s MarketRank Tool
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.